NCT02748863 - Study of Secukinumab With 2 mL Pre-filled Syringes | Biotech Hunter

Enrollment

214

Participants

Timeline

Start Date

December 12, 2016

Primary Completion Date

August 8, 2017

Study Completion Date

June 8, 2018

Conditions

Psoriasis

Interventions

DRUG

Placebo

2 mL + 2 x 1 mL Placebo s.c. at randomization, weeks 1, 3, and 4, thereafter 4-weekly until week 48

DRUG

Secukinumab 2 mL form

Secukinumab 300 mg/2mL + 2 x 1 mL placebo s.c. at randomization, week 1 , 3, 4, thereafter 4-weekly until Week 48

DRUG

Secukinumab 1 mL form

Secukinumab 150 mg/1mL x 2 + 2 mL placebo s.c. at randomization, week 1 , 3, 4, thereafter 4-weekly until Week 48

Trial Locations (52)

201

Novartis Investigative Site, Kopavogur

1012

Novartis Investigative Site, Riga

1200

Novartis Investigative Site, Brussels

4000

Novartis Investigative Site, Liège

10629

Novartis Investigative Site, Berlin

16059

Novartis Investigative Site, Bursa

23507

Novartis Investigative Site, Norfolk

28009

Novartis Investigative Site, Madrid

28046

Novartis Investigative Site, Madrid

29010

Novartis Investigative Site, Málaga

30060

Novartis Investigative Site, Marietta

31406

Novartis Investigative Site, Savannah

33155

Novartis Investigative Site, Miami

33647

Novartis Investigative Site, Bielefeld

35040

Novartis Investigative Site, Izmir

36003

Novartis Investigative Site, Pontevedra

37007

Novartis Investigative Site, Salamanca

45147

Novartis Investigative Site, Essen

46026

Novartis Investigative Site, Valencia

48013

Novartis Investigative Site, Bilbao

64506

Novartis Investigative Site, Saint Joseph

69120

Novartis Investigative Site, Heidelberg

77030

Novartis Investigative Site, Houston

77479

Novartis Investigative Site, Sugar Land

78218

Novartis Investigative Site, San Antonio

80337

Novartis Investigative Site, München

85032

Novartis Investigative Site, Phoenix

92708

Novartis Investigative Site, Fountain Valley

95438

Novartis Investigative Site, Fremont

97210

Novartis Investigative Site, Portland

97223

Novartis Investigative Site, Portland

98405

Novartis Investigative Site, Tacoma

107076

Novartis Investigative Site, Moscow

191123

Novartis Investigative Site, Saint Petersburg

194021

Novartis Investigative Site, Saint Petersburg

420012

Novartis Investigative Site, Kazan'

454092

Novartis Investigative Site, Chelyabinsk

07044

Novartis Investigative Site, Verona

T5K 1X3

Novartis Investigative Site, Edmonton

V3R 6A7

Novartis Investigative Site, Surrey

LV-5404

Novartis Investigative Site, Daugavpils

LV-3001

Novartis Investigative Site, Jelgava

LV-1003

Novartis Investigative Site, Riga

LV-3601

Novartis Investigative Site, Ventspils

LV-1001

Novartis Investigative Site, Riga

10-045

Novartis Investigative Site, Olsztyn

02-507

Novartis Investigative Site, Warsaw

08970

Novartis Investigative Site, Sant Joan Despí

DY1 2HQ

Novartis Investigative Site, Dudley

CB7 5JD

Novartis Investigative Site, Cambridge

DD1 9SY

Novartis Investigative Site, Dundee

RH1 5RH

Novartis Investigative Site, Surrey